Plain-English translation of NCT07356505 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a device called the Micra AV2, a tiny leadless pacemaker that helps your heart's upper and lower chambers work together properly. Researchers want to understand how well this device maintains the natural timing between heartbeats in patients with heart block, and whether it stays safe and effective over time.
Heart block prevents electrical signals from traveling normally between the upper and lower chambers of the heart, which can cause symptoms like fainting or fatigue. This trial will help doctors understand whether this newer, smaller pacemaker design can restore the natural rhythm better than older approaches.
You likely qualify if…
You likely don't qualify if…
You will have the Micra AV2 pacemaker surgically implanted through a small catheter procedure (no large incisions needed). After implantation, you'll attend follow-up visits at 6 months, 12 months, and up to 3 years to have your heart rhythm checked, your heart function evaluated with imaging, and your device tested to ensure it's working properly and safely.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
Belgium